{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:57:54Z","timestamp":1794315474142,"version":"4.9.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,12,24]],"date-time":"2013-12-24T00:00:00Z","timestamp":1387843200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s00415-013-7209-3","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T08:16:54Z","timestamp":1387786614000},"page":"1662-1676","source":"Crossref","is-referenced-by-count":302,"title":["Diagnosis and management of Neuro-Beh\u00e7et\u2019s disease: international consensus recommendations"],"prefix":"10.1007","volume":"261","author":[{"given":"Seema","family":"Kalra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Silman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulsen","family":"Akman-Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Bohlega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Borhani-Haghighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cris S.","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Houman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Mahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Salvarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros P.","family":"Sfikakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aksel","family":"Siva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Al-Araji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,24]]},"reference":[{"key":"7209_CR1","first-page":"1152","volume":"105","author":"H Beh\u00e7et","year":"1937","unstructured":"Beh\u00e7et H (1937) Uber residivierende, aphtose durch ein Virus verursachtes Geschwure am Mund, am Auge und an der Genitalien. Derm Wschr 105:1152\u20131157","journal-title":"Derm Wschr"},{"key":"7209_CR2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.rdc.2013.02.010","volume":"39","author":"G Hatemi","year":"2013","unstructured":"Hatemi G, Yazici Y, Yazici H (2013) Beh\u00e7et\u2019s syndrome. Rheum Dis Clin North Am 39:245\u2013261","journal-title":"Rheum Dis Clin North Am"},{"key":"7209_CR3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","volume":"54","author":"DH Verity","year":"1999","unstructured":"Verity DH, Marr JE, Ohno S (1999) Beh\u00e7et\u2019s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54:213\u2013220","journal-title":"Tissue Antigens"},{"key":"7209_CR4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3109\/09273948.2012.723112","volume":"20","author":"M Khairallah","year":"2012","unstructured":"Khairallah M, Accorinti M, Muccioli C, Kahloun R, Kempen JH et al (2012) Epidemiology of Beh\u00e7et disease. Ocul Immunol Inflamm 20:324\u2013335","journal-title":"Ocul Immunol Inflamm"},{"key":"7209_CR5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1474-4422(09)70015-8","volume":"8","author":"A Al-Araji","year":"2009","unstructured":"Al-Araji A, Kidd DP (2009) Neuro-Beh\u00e7et\u2019s disease: epidemiology, clinical characteristics, and management. Lancet Neurol 8:192\u2013204","journal-title":"Lancet Neurol"},{"key":"7209_CR6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1365-2648.2003.02537.x","volume":"41","author":"C Powell","year":"2003","unstructured":"Powell C (2003) The Delphi technique: myths and realities. J Adv Nurs 41:376\u2013382","journal-title":"J Adv Nurs"},{"key":"7209_CR7","doi-asserted-by":"crossref","unstructured":"Strober BE, Clay Cather J, Cohen D et al (2012) A Delphi consensus approach to challenging case scenarios in moderate-to-severe psoriasis: Part 2. Dermatol Ther (Heidelb) 2:2. Epub 2012 Mar 30","DOI":"10.1007\/s13555-012-0002-x"},{"key":"7209_CR8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.312.7023.71","volume":"312","author":"D Sackett","year":"1996","unstructured":"Sackett D, Rosenberg W, Muir Gray J, Haynes R, Richardson W (1996) Evidence based medicine: what it is and what it isn\u2019t. Br Med J 312:71\u201377","journal-title":"Br Med J"},{"key":"7209_CR9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ncprheum0436","volume":"3","author":"H Yazici","year":"2007","unstructured":"Yazici H, Fresko I, Yurdakul S (2007) Behcet\u2019s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 3:148\u2013155","journal-title":"Nat Clin Pract Rheumatol"},{"key":"7209_CR10","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/ard.2007.080432","volume":"67","author":"G Hatemi","year":"2008","unstructured":"Hatemi G, Silman A, Bang D et al (2008) Management of Behcet\u2019s disease: a systematic literature review for the EULAR evidence based recommendations for the management of Behcet\u2019s disease. Ann Rheum Dis 67:1656\u20131662","journal-title":"Ann Rheum Dis"},{"key":"7209_CR11","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/art.24642","volume":"61","author":"M Menthon","year":"2009","unstructured":"Menthon M, LaValley MP, Maldini C, Guillevin L, Mahr A (2009) HLA-B51\/B5 and the risk of Beh\u00e7et disease: a systematic review and meta-analysis of case control genetic association studies. Arthritis Rheum 61:1287\u20131296","journal-title":"Arthritis Rheum"},{"key":"7209_CR12","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/rheumatology\/ker428","volume":"51","author":"C Maldini","year":"2012","unstructured":"Maldini C, Lavalley MP, Cheminant M, de Menthon M, Mahr A (2012) Relationships of HLA-B51 or B5 genotype with Behcet\u2019s disease clinical characteristics: systematic review and meta-analyses of observational studies. Rheumatol (Oxford) 51:887\u2013900","journal-title":"Rheumatol (Oxford)"},{"key":"7209_CR13","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease (1990) Criteria for diagnosis of Behcet\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"7209_CR14","author":"F Davatchi","year":"2013","unstructured":"International Team for the Revision of the International Criteria for Beh\u00e7et\u2019s Disease (ITR-ICBD), Davatchi F, Assaad-Khalil S et al (2013) The international criteria for Beh\u00e7et\u2019s disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. doi: 10.1111\/jdv.12107","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"7209_CR15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-510X(99)00165-3","volume":"170","author":"S Al-Fahad","year":"1999","unstructured":"Al-Fahad S, Al-Araji A (1999) Neuro-Behcet\u2019s disease in Iraq: a study of 40 patients. J Neurol Sci 170:105\u2013111","journal-title":"J Neurol Sci"},{"key":"7209_CR16","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","volume":"122","author":"G Akman-Demir","year":"1999","unstructured":"Akman-Demir G, Serdaroglu P, Tasci B (1999) Clinical patterns of neurological involvement in Behcet\u2019s disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain 122:2171\u20132182","journal-title":"Brain"},{"key":"7209_CR17","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/brain\/122.11.2183","volume":"122","author":"D Kidd","year":"1999","unstructured":"Kidd D, Steuer A, Denman AM, Rudge P (1999) Neurological complications of Behcet\u2019s syndrome. Brain 122:2183\u20132194","journal-title":"Brain"},{"key":"7209_CR18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s004150170242","volume":"248","author":"A Siva","year":"2001","unstructured":"Siva A, Kantarci OH, Saip S et al (2001) Behcet\u2019s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 248:95\u2013103","journal-title":"J Neurol"},{"key":"7209_CR19","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jnnp.74.5.608","volume":"74","author":"A Al-Araji","year":"2003","unstructured":"Al-Araji A, Sharquie K, Al-Rawi Z (2003) Prevalence and patterns of neurological involvement in Behcet\u2019s disease: a prospective study from Iraq. J Neurol Neurosurg Psychiatry 74:608\u2013613","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7209_CR20","first-page":"415","volume-title":"Behcet\u2019s disease","author":"F Hentati","year":"1993","unstructured":"Hentati F, Fredj M, Gharbi N, Hamida M (1993) Clinical and biological aspects of neuro-Behcet\u2019s in Tunisia. In: Wechsler B, Godeau P (eds) Behcet\u2019s disease. Elsevier, Amsterdam, pp 415\u2013418"},{"key":"7209_CR21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/s10165-011-0533-5","volume":"22","author":"S Hirohata","year":"2012","unstructured":"Hirohata S, Kikuchi H, Sawada T et al (2012) Clinical characteristics of neuro-Behcet\u2019s disease in Japan: a multicenter retrospective analysis. Mod Rheumatol 22:405\u2013413","journal-title":"Mod Rheumatol"},{"key":"7209_CR22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121\u2013127","journal-title":"Ann Neurol"},{"key":"7209_CR23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/qjmed\/92.2.103","volume":"92","author":"JP Zajicek","year":"1998","unstructured":"Zajicek JP, Scolding NJ, Foster O et al (1998) Central nervous system sarcoidosis\u2014diagnosis and management. QJM 92:103\u2013117","journal-title":"QJM"},{"key":"7209_CR24","first-page":"429","volume-title":"Behcet\u2019s disease","author":"S Bohlega","year":"1993","unstructured":"Bohlega S, AlKawi MZ, Omer S et al (1993) Neuro-Behcet\u2019s: clinical syndromes and prognosis. In: Wechsler B, Godeau P (eds) Behcet\u2019s disease. Elsevier, Amsterdam, pp 429\u2013433"},{"key":"7209_CR25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.nrl.0000156343.16797.c4","volume":"11","author":"A Borhani-Haghighi","year":"2005","unstructured":"Borhani-Haghighi A, Pourmand R, Nikseresht AR (2005) Neuro-Behcet disease. A review. Neurologist 11:80\u201389","journal-title":"Neurologist"},{"key":"7209_CR26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00415-009-0145-6","volume":"56","author":"A Siva","year":"2009","unstructured":"Siva A, Saip S (2009) The spectrum of nervous system involvement in Beh\u00e7et\u2019s syndrome and its differential diagnosis. J Neurol 56:513\u2013529","journal-title":"J Neurol"},{"key":"7209_CR27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/jnnp.43.3.210","volume":"43","author":"S Motomura","year":"1998","unstructured":"Motomura S, Tabira T, Kuriowa Y et al (1998) A clinical comparative study of multiple sclerosis and neuro-Beh\u00e7et syndrome. J Neurol Neurosurg Psychiatry 43:210\u2013213","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7209_CR28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s002340050742","volume":"41","author":"O Coban","year":"1999","unstructured":"Coban O, Bahar S, Akman-Demir G et al (1999) Masked assessment of MRI findings: is it possible to differentiate neuro-Beh\u00e7et\u2019s disease from other central nervous system diseases? Neuroradiology 41:255\u2013260","journal-title":"Neuroradiology"},{"key":"7209_CR29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1468-1331.2007.01754.x","volume":"14","author":"N Yesilot","year":"2007","unstructured":"Yesilot N, Mutlu M, Gungor O, Baykal B, Serdaroglu P, Akman-Demir G (2007) Clinical characteristics and course of spinal cord involvement in Beh\u00e7et\u2019s disease. Eur J Neurol 14:729\u2013737","journal-title":"Eur J Neurol"},{"issue":"3 Suppl 77","key":"7209_CR30","first-page":"25","volume":"31","author":"G Saruhan-Direskeneli","year":"2013","unstructured":"Saruhan-Direskeneli G, Yent\u00fcr SP, Mutlu M et al (2013) Intrathecal oligoclonal IgG bands are infrequently found in neuro-Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 31(3 Suppl 77):25\u201327","journal-title":"Clin Exp Rheumatol"},{"key":"7209_CR31","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jnnp.58.5.548","volume":"58","author":"BN McLean","year":"1995","unstructured":"McLean BN, Miller D, Thompson EJ (1995) Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Beh\u00e7et\u2019s disease involving the nervous system. J Neurol Neurosurg Psychiatry 58:548\u2013554","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7209_CR32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0404.2005.00414.x","volume":"112","author":"D Reske","year":"2005","unstructured":"Reske D, Petereit HF, Heiss WD (2005) Difficulties in the differentiation of chronic inflammatory diseases of the central nervous system\u2013value of cerebrospinal fluid analysis and immunological abnormalities in the diagnosis. Acta Neurol Scand 112:207\u2013213","journal-title":"Acta Neurol Scand"},{"key":"7209_CR33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1468-1331.2006.01613.x","volume":"14","author":"FG Joseph","year":"2007","unstructured":"Joseph FG, Scolding NJ (2007) Neuro- Beh\u00e7et\u2019s disease in Caucasians: a study of 22 patients. Euro J Neurol 14:174\u2013180","journal-title":"Euro J Neurol"},{"key":"7209_CR34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1212\/WNL.41.3.405","volume":"41","author":"MZ Al Kawi","year":"1997","unstructured":"Al Kawi MZ, Bohlega S, Banna M (1997) MRI findings in neuro-Behcet\u2019s disease. Neurology 41:405\u2013408","journal-title":"Neurology"},{"key":"7209_CR35","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jnnp.56.7.793","volume":"56","author":"B Wechsler","year":"1993","unstructured":"Wechsler B, Dell\u2019lsola B, Vidailhet M et al (1993) MRI in 31 patients with Beh\u00e7et\u2019s disease and neurological involvement: prospective study with clinical correlation. J Neurol Neurosurg Psychiatry 56:793\u2013798","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7209_CR36","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF00596576","volume":"38","author":"O Coban","year":"1996","unstructured":"Coban O, Bahar S, Akman-Demir G et al (1996) A controlled study of reliability and validity of MRI findings in neuro-Beh\u00e7et\u2019s disease. Neuroradiology 38:312\u2013316","journal-title":"Neuroradiology"},{"key":"7209_CR37","first-page":"1015","volume":"20","author":"N Ko\u00e7er","year":"1999","unstructured":"Ko\u00e7er N, Islak C, Siva A, Saip S, Akman C, Kantarci O, Hamuryudan V (1999) CNS involvement in neuro-Beh\u00e7et syndrome: an MR study. Am J Neuroradiol 20:1015\u20131024","journal-title":"Am J Neuroradiol"},{"key":"7209_CR38","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/crad.2000.0675","volume":"56","author":"SH Lee","year":"2001","unstructured":"Lee SH, Yoon PH, Park SJ, Kim DI (2001) MRI findings in neuro-Behcet\u2019s disease. Clin Radiol 56:485\u2013494","journal-title":"Clin Radiol"},{"key":"7209_CR39","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00234-003-1102-1","volume":"45","author":"G Akman-Demir","year":"2003","unstructured":"Akman-Demir G, Bahar S, Coban O, Tasci B, Serdaroglu P (2003) Cranial MRI in Beh\u00e7et\u2019s disease: 134 examinations of 98 patients. Neuroradiology 45:851\u2013859","journal-title":"Neuroradiology"},{"key":"7209_CR40","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10067-010-1650-9","volume":"30","author":"A Borhani-Haghighi","year":"2011","unstructured":"Borhani-Haghighi A, Sarhadi S, Farahangiz S (2011) MRI findings of neuro-Beh\u00e7et\u2019s disease. Clin Rheumatol 30:765\u2013770","journal-title":"Clin Rheumatol"},{"key":"7209_CR41","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3174\/ajnr.A2477","volume":"32","author":"S Albayram","year":"2011","unstructured":"Albayram S, Saip S, Hasiloglu ZI et al (2011) Evaluation of parenchymal neuro-beh\u00e7et disease by using susceptibility-weighted imaging. Am J Neuroradiol 32:1050\u20131055","journal-title":"Am J Neuroradiol"},{"key":"7209_CR42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0923-1811(95)00439-4","volume":"11","author":"Y Yamakawa","year":"1996","unstructured":"Yamakawa Y, Sugita Y, Nagatani T et al (1996) Interleukin-6 (IL-6) in patients with Beh\u00e7et\u2019s disease. J Dermatol Sci 11:189\u2013195","journal-title":"J Dermatol Sci"},{"key":"7209_CR43","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cyto.2008.10.007","volume":"44","author":"G Akman-Demir","year":"2008","unstructured":"Akman-Demir G, Erdem Tuzun, Sema Icoz et al (2008) Interleukin-6 in neuro-Beh\u00e7et\u2019s disease: association with disease subsets and long-term outcome. Cytokine 44:373\u2013376","journal-title":"Cytokine"},{"key":"7209_CR44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/clin.1996.4268","volume":"82","author":"S Hirohata","year":"1997","unstructured":"Hirohata S, Isshi K, Oguchi H et al (1997) Cerebrospinal fluid interleukin-6 in progressive neuro-Beh\u00e7et\u2019s syndrome. Clin Immunol Immunopathol 82:12\u201317","journal-title":"Clin Immunol Immunopathol"},{"key":"7209_CR45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2003.08.040","volume":"145","author":"G Saruhan-Direskeneli","year":"2003","unstructured":"Saruhan-Direskeneli G, Yentur SP, Akman-Demir G, Isik N, Serdaroglu P (2003) Cytokines and chemokines in neuro-Behcet\u2019s disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol 145:127\u2013134","journal-title":"J Neuroimmunol"},{"key":"7209_CR46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.2006.056804","volume":"66","author":"K Fujikawa","year":"2007","unstructured":"Fujikawa K, Aratake K, Kawakami A et al (2007) Successful treatment of refractory neuro-Beh\u00e7et\u2019s disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile. Ann Rheumat Dis 66:136\u2013137","journal-title":"Ann Rheumat Dis"},{"key":"7209_CR47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2008.05.002","volume":"272","author":"H Kikuchi","year":"2008","unstructured":"Kikuchi H, Aramaki K, Hirohata S (2008) Effect of infliximab in progressive neuro-Behcet\u2019s syndrome. J Neurol Sci 272:99\u2013105","journal-title":"J Neurol Sci"},{"key":"7209_CR48","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/rheumatology\/37.11.1148","volume":"37","author":"T Budak-Alpdogan","year":"1998","unstructured":"Budak-Alpdogan T, Demir\u00e7ay, Alpdogan O et al (1998) Skin hyperreactivity of Beh\u00e7et\u2019s patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disorders. Br J Rheumatol 37:1148\u20131151","journal-title":"Br J Rheumatol"},{"issue":"4 Suppl 50","key":"7209_CR49","first-page":"S91","volume":"26","author":"I Hatemi","year":"2008","unstructured":"Hatemi I, Hatemi G, Celik AF et al (2008) Frequency of pathergy phenomenon and other features of Beh\u00e7et\u2019s syndrome among patients with inflammatory bowel disease. Clin Exp Rheumatol 26(4 Suppl 50):S91\u2013S95","journal-title":"Clin Exp Rheumatol"},{"key":"7209_CR50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard.43.1.74","volume":"43","author":"H Yazici","year":"1984","unstructured":"Yazici H, Chamberlain MA, Tuzun Y et al (1984) A comparative study of the pathergy among Turkish and British patients with Behcet\u2019s disease. Ann Rheumc Dis 43:74\u201375","journal-title":"Ann Rheumc Dis"},{"key":"7209_CR51","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/rheumatology\/40.6.668","volume":"40","author":"A G\u00fcl","year":"2001","unstructured":"G\u00fcl A, Uyar FA, Inanc M et al (2001) Lack of association of HLA-B*51 with a severe disease course in Beh\u00e7et\u2019s disease. Rheumatology 40:668\u2013672","journal-title":"Rheumatology"},{"issue":"5 Suppl 24","key":"7209_CR52","first-page":"S31","volume":"19","author":"HK Chang","year":"2001","unstructured":"Chang HK, Kim JU, Cheon KS, Chung HR, Lee KW, Lee IH (2001) HLA-B51 and its allelic types in association with Beh\u00e7et\u2019s disease and recurrent aphthous stomatitis in Korea. Clin Exp Rheumatol 19(5 Suppl 24):S31\u2013S35","journal-title":"Clin Exp Rheumatol"},{"key":"7209_CR53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1620\/tjem.216.109","volume":"216","author":"H Turker","year":"2008","unstructured":"Turker H, Terzi M, Bayrak O, Cengiz N, Onar M, Us O (2008) Visual evoked potentials in differential diagnosis of multiple sclerosis and neurobehcet\u2019s disease. Tohoku J Exp Med 216:109\u2013116","journal-title":"Tohoku J Exp Med"},{"key":"7209_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1620\/tjem.207.1","volume":"207","author":"H Kececi","year":"2005","unstructured":"Kececi H (2005) Behcet\u2019s disease without neurological manifestations. Tohoku J Exp Med 207:1","journal-title":"Tohoku J Exp Med"},{"key":"7209_CR55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1620\/tjem.206.15","volume":"206","author":"HI Ozisik","year":"2005","unstructured":"Ozisik HI, Karlidag R, Hazneci E, Kizkin S, Ozcan C (2005) Cognitive event-related potential and neuropsychological findings in Beh\u00e7et\u2019s disease without neurological manifestations. Tohoku J Exp Med 206:15\u201322","journal-title":"Tohoku J Exp Med"},{"key":"7209_CR56","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/00207450500403165","volume":"116","author":"O Anlar","year":"2006","unstructured":"Anlar O, Akdeniz N, Tombul T, Calka O, Bilgili SG (2006) Visual evoked potential findings in Behcet\u2019s disease without neurological manifestations. Int J Neurosci 116:281\u2013287","journal-title":"Int J Neurosci"},{"issue":"5 Suppl 42","key":"7209_CR57","first-page":"S65","volume":"24","author":"N Yesilot","year":"2006","unstructured":"Yesilot N, Shehu M, Oktem-Tanor O, Serdaroglu P, Akman-Demir G (2006) Silent neurological involvement in Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 24(5 Suppl 42):S65\u2013S70","journal-title":"Clin Exp Rheumatol"},{"key":"7209_CR58","first-page":"235","volume-title":"Beh\u00e7et\u2019s Disease","author":"G Inaba","year":"1981","unstructured":"Inaba G (1981) Clinical features of Neuro-Beh\u00e7et\u2019s syndrome. In: Inaba G (ed) Beh\u00e7et\u2019s Disease. University of Tokyo Press, Tokyo, pp 235\u2013246"},{"key":"7209_CR59","first-page":"197","volume-title":"Beh\u00e7et\u2019s disease","author":"H Hayashi","year":"1981","unstructured":"Hayashi H, Fukuda Y, Kuwabara N (1981) Pathological studies on Neuro-Beh\u00e7et\u2019s disease. In: Inaba G (ed) Beh\u00e7et\u2019s disease. University of Tokyo Press, Tokyo, pp 197\u2013211"},{"key":"7209_CR60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2007.09.041","volume":"267","author":"S Hirohata","year":"2008","unstructured":"Hirohata S (2008) Histopathology of central nervous system lesions in Beh\u00e7et\u2019s disease. J Neurol Sci 267:41\u201347","journal-title":"J Neurol Sci"},{"key":"7209_CR61","first-page":"650","volume":"26","author":"K Matsuo","year":"2005","unstructured":"Matsuo K, Yamada K, Nakajima K, Nakagawa M (2005) Neuro-Beh\u00e7et disease mimicking brain tumor. Am J Neuroradiol 26:650\u2013653","journal-title":"Am J Neuroradiol"},{"key":"7209_CR62","doi-asserted-by":"crossref","unstructured":"Appenzeller S, de Castro R, Queiroz L de S et al (2006) Brain tumor-like lesion in Beh\u00e7et disease. Rheumatol Int 26:577\u2013580","DOI":"10.1007\/s00296-005-0082-3"},{"key":"7209_CR63","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11940-011-0120-2","volume":"13","author":"G Akman-Demir","year":"2011","unstructured":"Akman-Demir G, Saip S, Siva A (2011) Beh\u00e7et\u2019s Disease. Curr Treat Options Neurol 13:290\u2013310","journal-title":"Curr Treat Options Neurol"},{"key":"7209_CR64","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","volume":"69","author":"GK Bertsias","year":"2010","unstructured":"Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN (2010) EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 69:2074\u20132082","journal-title":"Ann Rheum Dis"},{"issue":"4 Suppl 67","key":"7209_CR65","first-page":"S64","volume":"29","author":"E Shugaiv","year":"2011","unstructured":"Shugaiv E, T\u00fcz\u00fcn E, Mutlu M, Kiyat-Atamer A, Kurtuncu M, Akman-Demir G (2011) Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Beh\u00e7et\u2019s disease with parenchymal involvement: presentation of four cases. Clin Exp Rheumatol 29(4 Suppl 67):S64\u2013S67","journal-title":"Clin Exp Rheumatol"},{"key":"7209_CR66","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-510X(98)00165-8","volume":"159","author":"S Hirohata","year":"1998","unstructured":"Hirohata S, Suda H, Hashimoto T (1998) Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Beh\u00e7et\u2019s disease. J Neurol Sci 159:181\u2013185","journal-title":"J Neurol Sci"},{"key":"7209_CR67","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/0-306-48382-3_117","volume":"528","author":"H Kikuchi","year":"2003","unstructured":"Kikuchi H, Aramaki K, Hirohata S (2003) Low dose MTX for progressive neuro-Beh\u00e7et\u2019s disease. A follow-up study for 4\u00a0years. Adv Exp Med Biol 528:575\u2013578","journal-title":"Adv Exp Med Biol"},{"key":"7209_CR68","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0002-9343(84)90753-8","volume":"76","author":"JD O\u2019Duffy","year":"1984","unstructured":"O\u2019Duffy JD, Robertson DM, Goldstein NP (1984) Chlorambucil in the treatment of uveitis and meningoencephalitis of Beh\u00e7et\u2019s disease. Am J Med 76:75\u201384","journal-title":"Am J Med"},{"key":"7209_CR69","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.neurol.2011.09.006","volume":"168","author":"EH Ait Ben Haddou","year":"2012","unstructured":"Ait Ben Haddou EH, Imounan F, Regragui W et al (2012) Neurological manifestations of Beh\u00e7et\u2019s disease: evaluation of 40 patients treated by cyclophosphamide. Rev Neurol (Paris) 168:344\u2013349","journal-title":"Rev Neurol (Paris)"},{"key":"7209_CR70","first-page":"181","volume":"32","author":"H Sarwar","year":"2005","unstructured":"Sarwar H, McGrath H Jr, Espinoza LR (2005) Successful treatment of long-standing neuro-Beh\u00e7et\u2019s disease with infliximab. J Rheumatol 32:181\u2013183","journal-title":"J Rheumatol"},{"key":"7209_CR71","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/art.23345","volume":"59","author":"N Pipitone","year":"2008","unstructured":"Pipitone N, Olivieri I, Padula A et al (2008) Infliximab for the treatment of Neuro-Beh\u00e7et\u2019s disease: a case series and review of the literature. Arthritis Rheum 59:285\u2013290","journal-title":"Arthritis Rheum"},{"key":"7209_CR72","unstructured":"Al-Araji A, Siva A, Saip S et al (2010) Treatment of Neuro-Behcet\u2019s disease with infliximab. An international multi-centre case-series of 18 patients. Clin Exp Rheumatol 28 (Suppl 60): S119"},{"key":"7209_CR73","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jneuroim.2011.08.014","volume":"239","author":"A Fasano","year":"2011","unstructured":"Fasano A, D\u2019Agostino M, Caldarola G, Feliciani C, De Simone C (2011) Infliximab monotherapy in neuro-Beh\u00e7et\u2019s disease: four year follow-up in a long-standing case resistant to conventional therapies. J Neuroimmunol 239:105\u2013107","journal-title":"J Neuroimmunol"},{"key":"7209_CR74","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00296-009-1213-z","volume":"31","author":"A Giardina","year":"2011","unstructured":"Giardina A, Ferrante A, Ciccia F, Vadal\u00e0 M, Giardina E, Triolo G (2011) One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Beh\u00e7et\u2019s disease refractory to standard immunosuppressive drugs. Rheumatol Int 31:33\u201337","journal-title":"Rheumatol Int"},{"issue":"4 Suppl 60","key":"7209_CR75","first-page":"S102","volume":"28","author":"P Leccese","year":"2010","unstructured":"Leccese P, D\u2019Angelo S, Angela P, Coniglio G, Olivieri I (2010) Switching to adalimumab is effective in a case of neuro-Beh\u00e7et\u2019s disease refractory to infliximab. Clin Exp Rheumatol 28(4 Suppl 60):S102","journal-title":"Clin Exp Rheumatol"},{"issue":"4 Suppl 67","key":"7209_CR76","first-page":"S54","volume":"29","author":"I Olivieri","year":"2011","unstructured":"Olivieri I, Leccese P, D\u2019Angelo S et al (2011) Efficacy of adalimumab in patients with Beh\u00e7et\u2019s disease unsuccessfully treated with infliximab. Clin Exp Rheumatol 29(4 Suppl 67):S54\u2013S57","journal-title":"Clin Exp Rheumatol"},{"key":"7209_CR77","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.clineuro.2006.11.002","volume":"109","author":"JE Alty","year":"2007","unstructured":"Alty JE, Monaghan TM, Bamford JM (2007) A patient with neuro-Beh\u00e7et\u2019s disease is successfully treated with etanercept: further evidence for the value of TNF alpha blockade. Clin Neurol Neurosurg 109:279\u2013281","journal-title":"Clin Neurol Neurosurg"},{"key":"7209_CR78","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clineuro.2011.10.024","volume":"114","author":"LS Shapiro","year":"2012","unstructured":"Shapiro LS, Farrell J, Borhani-Haghighi A (2012) Tocilizumab treatment for neuro-Behcet\u2019s disease, the first report. Clin Neurol Neurosurg 114:297\u2013298","journal-title":"Clin Neurol Neurosurg"},{"key":"7209_CR79","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00041327-200106000-00011","volume":"21","author":"JC Nichols","year":"2001","unstructured":"Nichols JC, Ince A, Akduman L, Mann ES (2001) Interferon-a2a treatment of neuro-Beh\u00e7et disease. J Neuroophthalmol 21:109\u2013111","journal-title":"J Neuroophthalmol"},{"key":"7209_CR80","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/qjmed\/hcq125","volume":"103","author":"A Monastirli","year":"2010","unstructured":"Monastirli A, Chroni E, Georgiou S et al (2010) Interferon-\u03b1 treatment for acute myelitis and intestinal involvement in severe Beh\u00e7et\u2019s disease. QJM 103:787\u2013790","journal-title":"QJM"},{"key":"7209_CR81","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semarthrit.2010.09.002","volume":"41","author":"A Arida","year":"2011","unstructured":"Arida A, Fragiadaki K, Giavri E, Sfikakis PP (2011) Anti-TNF agents for Beh\u00e7et\u2019s disease: analysis of published data on 369 patients. Semin Arthritis Rheum 41:61\u201370","journal-title":"Semin Arthritis Rheum"},{"key":"7209_CR82","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0161-6420(99)90120-3","volume":"106","author":"S Kotake","year":"1999","unstructured":"Kotake S, Higashi K, Yoshikawa K, Sasamoto Y, Okamoto T, Matsuda H (1999) Central nervous system symptoms in patients with Beh\u00e7et\u2019s Beh\u00e7et disease receiving ciclosporin therapy. Ophthalmology 106:586\u2013589","journal-title":"Ophthalmology"},{"key":"7209_CR83","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1442-9071.2001.00445.x","volume":"29","author":"Y Kato","year":"2001","unstructured":"Kato Y, Numaga J, Kato S et al (2001) Central nervous system in a population of Beh\u00e7et\u2019s disease patients with refractory uveitis treated with cyclosporine A. Clin Exp Ophthalmol 29:335\u2013336","journal-title":"Clin Exp Ophthalmol"},{"key":"7209_CR84","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s10067-005-0070-8","volume":"25","author":"I K\u00f6tter","year":"2006","unstructured":"K\u00f6tter I, G\u00fcnaydin I, Batra M et al (2006) CNS involvement occurs more frequently in patients with Beh\u00e7et\u2019s disease under cyclosporin A than under other medications\u2013results of a retrospective analysis of 117 cases. Clin Rheumatol 25:482\u2013486","journal-title":"Clin Rheumatol"},{"key":"7209_CR85","first-page":"S84","volume":"26","author":"G Akman-Demir","year":"2008","unstructured":"Akman-Demir G, Ayranci O, Kurtuncu M, Vanli EN, Mutlu M, Tugal-Tutkun I (2008) Ciclosporin for Beh\u00e7et\u2019s uveitis: is it associated with an increased risk of neurological involvement? Clin Exp Rheumatol 26:S84\u2013S90","journal-title":"Clin Exp Rheumatol"},{"key":"7209_CR86","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(07)70029-7","volume":"6","author":"MG Bousser","year":"2007","unstructured":"Bousser MG, Ferro JM (2007) Cerebral venous thrombosis: an update. Lancet Neurol 6:162\u2013170","journal-title":"Lancet Neurol"},{"key":"7209_CR87","first-page":"735","volume":"30","author":"OE Tayer-Shifman","year":"2012","unstructured":"Tayer-Shifman OE, Seyahi E, Nowatzky J, Ben-Chetrit E (2012) Major vessel thrombosis in Beh\u00e7et\u2019s disease: the dilemma of anticoagulant therapy\u2014the approach of rheumatologists from different countries. Clin Exp Rheumatol 30:735\u2013740","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"7209_CR88","doi-asserted-by":"crossref","first-page":"e2011026","DOI":"10.4084\/mjhid.2011.026","volume":"3","author":"E Seyahi","year":"2011","unstructured":"Seyahi E, Yurdakul S (2011) Beh\u00e7et\u2019s syndrome and thrombosis. Mediterr J Hematol Infect Dis 3(1):e2011026. doi: 10.4084\/MJHID.2011.026","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"7209_CR89","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/BOR.0b013e3283410088","volume":"23","author":"KT Calamia","year":"2011","unstructured":"Calamia KT, Schirmer M, Melikoglu M (2011) Major vessel involvement in Beh\u00e7et\u2019s disease: an update. Curr Opin Rheumatol 23:24\u201331","journal-title":"Curr Opin Rheumatol"},{"key":"7209_CR90","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00415-010-5885-9","volume":"258","author":"D Aguiar de Sousa","year":"2011","unstructured":"Aguiar de Sousa D, Mestre T, Ferro JM (2011) Cerebral venous thrombosis in Beh\u00e7et\u2019s disease: a systematic review. J Neurol 258:719\u2013727","journal-title":"J Neurol"},{"key":"7209_CR91","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1526-4610.2007.01041.x","volume":"48","author":"A Borhani-Haghighi","year":"2008","unstructured":"Borhani-Haghighi A, Aflaki E, Ketabchi L (2008) The prevalence and characteristics of different types of headache in patients with Beh\u00e7et\u2019s disease, a case-control study. Headache 48:424\u2013429","journal-title":"Headache"},{"key":"7209_CR92","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1468-2982.2005.01017.x","volume":"26","author":"E Aykutlu","year":"2006","unstructured":"Aykutlu E, Baykan B, Akman-Demir G, Topcular B, Ertas M (2006) Headache in Beh\u00e7et\u2019s disease. Cephalalgia 26:180\u2013186","journal-title":"Cephalalgia"},{"key":"7209_CR93","first-page":"911","volume":"45","author":"S Saip","year":"2005","unstructured":"Saip S, Siva A, Altintas A et al (2005) Headache in Beh\u00e7et\u2019s syndrome headache 45:911\u2013919","journal-title":"Headache in Beh\u00e7et\u2019s syndrome headache"},{"key":"7209_CR94","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/003693305700200504","volume":"2","author":"J Rankin","year":"1957","unstructured":"Rankin J (1957) Cerebral vascular accidents in patients over the age of 60. Scott Med J 2:200\u2013215","journal-title":"Scott Med J"},{"key":"7209_CR95","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1161\/01.STR.19.12.1497","volume":"19","author":"R Bonita","year":"1988","unstructured":"Bonita R, Beaglehole R (1988) Modification of Rankin scale: recovery of motor function after stroke. Stroke 19:1497\u20131500","journal-title":"Stroke"},{"key":"7209_CR96","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/01.STR.0000027437.22450.BD","volume":"33","author":"JL Wilson","year":"2002","unstructured":"Wilson JL, Hareendran A, Grant M et al (2002) Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin scale. Stroke 33:2243\u20132246","journal-title":"Stroke"},{"key":"7209_CR97","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/01.STR.0000157596.13234.95","volume":"36","author":"JL Wilson","year":"2005","unstructured":"Wilson JL, Hareendran A, Hendry A et al (2005) Reliability of the modified Rankin scale across multiple raters: benefits of a structured interview. Stroke 36:777\u2013781","journal-title":"Stroke"},{"key":"7209_CR98","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444\u20131452","journal-title":"Neurology"},{"issue":"Suppl. 50","key":"7209_CR99","first-page":"S1","volume":"26","author":"M Kurtuncu","year":"2008","unstructured":"Kurtuncu M, Tuzun E, Mutlu M, Pehlivan M, Serdaroglu P, Akman-Demir G (2008) Clinical patterns and course of neuro-Beh\u00e7et\u2019s disease: analysis of 354 patients comparing cases presented before and after 1990. Clin Exp Rheumatol 26(Suppl. 50):S1\u2013S47","journal-title":"Clin Exp Rheumatol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-013-7209-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7209-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7209-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T04:33:23Z","timestamp":1564979603000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-013-7209-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,24]]},"references-count":99,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["7209"],"URL":"https:\/\/doi.org\/10.1007\/s00415-013-7209-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,24]]}}}